“Dolutegravir is approved for use  for HIV Infection and is available as 50mg film coated tablets. Integrase inhibitors, such as elvitegravir and raltegravir, can be used in combination with other antiretroviral drugs to treat HIV infection.Dolutegravir for HIV Infection PDFDolutegravir also inhibits HIV integrase to disrupt viral replication. Unlike raltegravir, dolutegravir can be given once daily and unlike elvitegravir it does not need ‘boosting’ with other drugs to have an effect.” The latest information on this drug is enclosed and published by The Australian Prescriber!